EME Equity Market – April 2024 Market performance – green across all geographies, with Turkey outperforming. The MSCI EM Europe Index was up 5.3% mom in EUR terms and 4.2% mom in USD in April; while the Turkish ISE30 saw the strongest performance, adding 11.6% mom; followed by the Hungarian BUX (+5.0% mom); the Czech PX (+2.8% mom); the Greek ASE (+1.8% mom), the Polish WIG20 (+1.2% mom) and the Romanian BET (+0.1% mom) (all in EUR terms).
BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - ...
L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) vs Au...
>Calendar and FX certainly help but let’s not overlook the volume-driven underlying growth - Sales grew at a pace of +19% y-o-y to € 8.1bn (vs +17% in Q4) with the group’s l-f-l expanding at +6% (vs +10% in Q4). By business, Biedronka sales grew +19% to € 5.8bn, accelerating vs Q4 (+19%) helped by the calendar effect (3pp) and the FX (8pp). L-f-L only deteriorated 50bp q-o-q to 4.6% which is remarkable in a disinflationary context and proves right Biedronka’s volume-d...
With Q1 topping expectations in terms of both sales and EBITDA, notably thanks to Biedronla, we foresee a positive share price reaction this morning. But reiterated gloomy FY guidance combined with no early signs of the price war easing in Poland still suggests caution is advisable.
HEADLINES: • Jeronimo Martins: small beat in 1Q24 NEUTRAL • Inter Cars: 4Q23 net profit in line with prelims, a miss vs. our initial forecasts due to lower gross margin NEUTRAL • Mo-BRUK: 4Q23 earnings call takeaways – supportive 2024E outlook POSITIVE • Shoper: earnings call takeaways – strong April, optimistic on 2024E outlook POSITIVE • Türkiye macro: MPC takes a pause, but hiking cycle not over yet • Uzbekistan macro: CBU keeps rates on hold • Polish banks: Polish Supreme Court reconfirms th...
HEADLINES: • Kaspi.kz: 1Q24 highlights Kruk: buys more portfolios in Italy • Tupras: launches USD 256m propylene investment NEUTRAL • Turkish banks: coverage UNDER REVIEW • Sipchem: 1Q24E results preview (due on 25 April) NEUTRAL • Jeronimo Martins: 1Q24E results preview – 11% yoy EBITDA growth expected (due on 26 April, before the open) • Erste Bank: 1Q24E preview (due on 30 April) • BRD-GSG: 1Q24E preview (due on 2 May) NEUTRAL • PKO BP: 1Q24E preview (due on 9 May) • Banca Transilvania: 1Q24E...
Ahead of Q1 results on 26th April, we have cut our FY 2024-26 EPS by c.5% and our PT from EUR20 to EUR19 to reflect steeper food disinflation with food deflation becoming a reality across all geographies for Q2, while the price war in Poland is escalating further. Despite adopting the right long-te
EME Equity Market – March 2024 Market performance – mixed performances in March, with the Romanian BET outperforming. The MSCI EM Europe Index declined by 0.3% mom in EUR terms and 0.4% mom in USD in March. The Romanian BET reported the strongest performance, adding 7.1% mom in EUR terms, followed by the Czech PX and the Polish WIG20 (+4.1% and 1.0% mom, in EUR terms, respectively). Greece saw a relatively muted performance (-0.2% mom in EUR terms), while Hungary (-1.1% mom in EUR terms) and Tür...
HEADLINES: • CD Projekt: 13% beat vs. our 4Q23 EBITDA forecast, on stronger revenues (CP77 IP) POSITIVE • Al Arabia Outdoor Advertising: mixed 4Q23 results NEUTRAL • Cimsa: 2023 financial results review • Tauron: reports 4Q23 EBITDA of PLN 674m , 44% lower qoq, but 83% higher yoy NEUTRAL • Asseco Poland: key takeaways from the 4Q23 earnings call NEUTRAL • Romanian energy: government adopts emergency ordinance, with amended regulations for the energy sector NEUTRAL • Bank of Georgia: receives app...
Based on our local coverage from Spain, the Netherlands and France and in an environment of decelerating inflation, we set the following hierarchy: Jeronimo Martins as our Top Pick for its growth potential, while in the slow-growth retail category, we favour Ahold Delhaize over Carrefour (downgraded to Neutral) or Colruyt. - >Managing inflation & food inflation deceleration: the name of the game for 2024 - The key topic for food retailers in 2024 will be how they manag...
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we comment on the US-Europe decoupling as US GDP growth forecasts for 2024 become in
>Q4 2024 outlook: company sees some signs of food inflation abatement - As usual, management’s outlook for 2024 was unspecific in terms of sales growth or margins, they just stated that cost inflation (rent and salaries) and Food CPI deflation will pressure the margins and that management will keep the focus on growing volumes. The company stated that the group will face tough comps in FY 2024 yet they believe that the strength and differentiation of their value prop...
With food deflation now the base scenario for Jeronimo Martins in H1 while a price war is reviving in Poland, we expect sluggish momentum during H1 with low to no top-line growth and EBITDA/FCF under significant pressure. PT cut from EUR21 to EUR20. Pending a potential improvement in momentum as of
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
We are initiating coverage of Lonza with a target price of CHF 535 and an Outperform rating. As one of the world's leading contract development and manufacturing organisations (CDMO), Lonza is predestined to benefit from the sustainable drivers of this industry. The group's global presence and strong market positions in the growth areas of biologics and cell and gene therapy (CGT) will fuel double-digit sales growth and >30% EBITDA margins in the medium term. Despite significant growt...
>Solid inflation-fuelled sales - The company released its Q4 sales earlier this year. Sales grew at a pace of +17% y-o-y to € 8.1bn (vs +22% in Q3) with the group’s l-f-l expanding at +10% (vs +12% in Q3). By business, Biedronka sales grew +17% to € 5.7bn, decelerating vs Q3 (+24%) as the lower LFL (+5.1% Q4 vs +13% in Q3) is partially offset by FX (+8pp) and space growth (4pp). The price impact is already negative for certain categories in Q4. Hebe: sales grew +32% t...
Jeronimo Martins has officially admitted 2024 will be a tough year marked by food deflation and a revived price war in Poland, issuing disappointing guidance for stronger margin pressure and lower FCF generation. This confirms the fears that led us to downgrade the stock in mid-January, and we now
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.